S19 Investigation of Linerixibat 40 Mg BID for Cholestatic Pruritus of Primary Biliary Cholangitis; Further Data From the Phase 2b GLIMMER Study to Support the Phase 3 GLISTEN Study. (October 2022) - Fettiplace, James; Swift, Brandon; Zhang, Shu; Von Maltzahn, Robyn